Stroke-SCORE: Personalizing Acute Ischemic Stroke Treatment to Improve Patient Outcomes.

J Pers Med · 2025 · PMC11766924 · PMID 39852210

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

borderline significantp = 0.055so close (0.05 < p ≤ 0.1)

Notably, differences in 90-day mRS across treatments were statistically significant in the low-risk group ( p < 0.001), borderline significant in the moderate-risk group ( p = 0.055), and not significant in the high-risk group ( p = 0.157).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.